(Allergan plc)

	AGN latest price $125.0700 (-1.14%) ($124.6700 - $127.4000) on Thu. Jun. 6, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.78% (three month average)
RSI	26
Latest Price	$125.0700(-1.14%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.4% a day on average for past five trading days.
Weekly Trend	AGN declines -5.2% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(47%)    XLV(46%)    ARKG(45%)    IVE(45%)    IWD(45%)
Factors Impacting AGN price	AGN will decline at least -0.89% in a week (0% probabilities).   VXX(-38%)    TLT(-22%)    IFRA(-20%)    GDX(-5%)    BWX(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.89% (StdDev 1.78%)
Hourly BBV	0 ()
Intraday Trend	-0.7%

1 - 5 Day Possible Target	$117.04(-6.42%)
Resistance Level	$132.83
5 Day Moving Average	$125.05(0.02%)
10 Day Moving Average	$127.61(-1.99%)
20 Day Moving Average	$132.83(-5.84%)
To recent high	-18.9%
To recent low	2.6%
Market Cap	$41.236b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed